Figure 1. Antitumor efficacy of high and low-affinity CD8⁺ T cells. (A and B) 8–9 week old RIP-Tag2-HA mice were immunized with cognate peptide and polyI:C in IFA and Clone 1 (A) or Clone 4 cells (B) (2 × 10⁵) were injected i.v. Glucose levels in the blood were measured at the indicated time points, and each line represents one mouse. Data are representative of two independent experiments.